Posted 25th February 2026
Posted 1 week ago
By NHP Office
TCD Standards and Guidance - 3rd Edition
The TCD QA Standards working group have published the 3rd Edition of Standards and Guidance in February 2026.
The haemoglobinopathy community is constantly evolving. Here we share some highlights of the NHP, its network members and its stakeholders regarding advances in their improvement, harmonisation and equity goals and efforts.
The TCD QA Standards working group have published the 3rd Edition of Standards and Guidance in February 2026.
Learn more about the NHP Cellular Therapy Operational Group (CTG)
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
The TCD QA Standards working group have published the 3rd Edition of Standards and Guidance in February 2026.
Learn more about the NHP Cellular Therapy Operational Group (CTG)
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
The TCD QA Standards working group have published the 3rd Edition of Standards and Guidance in February 2026.
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
The NHP activity report for 2023/2024 (published 21 November 2024) gives an overview of its core and partner-related activities.